Study examined the cost effectiveness of rituximab based chemoimmunotherapy for treatment of DLBCL in Malawi.
Home / Resource Library / Comparison of best supportive care, CHOP, or R-CHOP for treatment of diffuse large B-cell lymphoma in Malawi: a cost-effectiveness analysis